Data-Driven Differential Diagnosis of Dementia Using Multiclass Disease State Index Classifier

Data-Driven Differential Diagnosis of Dementia Using Multiclass Disease State Index Classifier

Clinical decision support systems (CDSSs) hold potential for the differential diagnosis of neurodegenerative diseases. We developed a novel CDSS, the PredictND tool, designed for differential diagnosis of different types of dementia. It combines information obtained from multiple diagnostic tests su...

Full description

Bibliographic Details
Main Authors:	Antti Tolonen, Hanneke F. M. Rhodius-Meester, Marie Bruun, Juha Koikkalainen, Frederik Barkhof, Afina W. Lemstra, Teddy Koene, Philip Scheltens, Charlotte E. Teunissen, Tong Tong, Ricardo Guerrero, Andreas Schuh, Christian Ledig, Marta Baroni, Daniel Rueckert, Hilkka Soininen, Anne M. Remes, Gunhild Waldemar, Steen G. Hasselbalch, Patrizia Mecocci, Wiesje M. van der Flier, Jyrki Lötjönen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-04-01
Series:	Frontiers in Aging Neuroscience
Subjects:	neurodegenerative diseases classification decision support Alzheimer’s disease frontotemporal lobar degeneration vascular dementia
Online Access:	http://journal.frontiersin.org/article/10.3389/fnagi.2018.00111/full

Similar Items

Differential diagnosis of neurodegenerative diseases using structural MRI data
by: Juha Koikkalainen, et al.
Published: (2016-01-01)

Five-class differential diagnostics of neurodegenerative diseases using random undersampling boosting
by: Tong Tong, et al.
Published: (2017-01-01)

Disease-related determinants are associated with mortality in dementia due to Alzheimer’s disease
by: Hanneke F. M. Rhodius-Meester, et al.
Published: (2018-02-01)

Evaluating combinations of diagnostic tests to discriminate different dementia types
by: Marie Bruun, et al.
Published: (2018-01-01)

Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy.
by: Hanneke F M Rhodius-Meester, et al.
Published: (2020-01-01)

MRI Visual Ratings of Brain Atrophy and White Matter Hyperintensities across the Spectrum of Cognitive Decline Are Differently Affected by Age and Diagnosis
by: Hanneke F. M. Rhodius-Meester, et al.
Published: (2017-05-01)

Detecting frontotemporal dementia syndromes using MRI biomarkers
by: Marie Bruun, et al.
Published: (2019-01-01)

cCOG: A web‐based cognitive test tool for detecting neurodegenerative disorders
by: Hanneke F.M. Rhodius‐Meester, et al.
Published: (2020-01-01)

Impact of a clinical decision support tool on prediction of progression in early-stage dementia: a prospective validation study
by: Marie Bruun, et al.
Published: (2019-03-01)

Biomarker testing in MCI patients—deciding who to test
by: Ingrid S. van Maurik, et al.
Published: (2021-01-01)

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
by: Inger van Steenoven, et al.
Published: (2019-10-01)

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment
by: Mara ten Kate, et al.
Published: (2017-09-01)

Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease
by: Ellen Dicks, et al.
Published: (2019-01-01)

Disturbed oscillatory brain dynamics in subcortical ischemic vascular dementia
by: van Straaten Elisabeth CW, et al.
Published: (2012-07-01)

Microbleeds are associated with depressive symptoms in Alzheimer's disease
by: Anna E. Leeuwis, et al.
Published: (2018-01-01)

Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic review
by: Arno de Wilde, et al.
Published: (2018-07-01)

Single-subject grey matter graphs in Alzheimer's disease.
by: Betty M Tijms, et al.
Published: (2013-01-01)

Correction: Single-Subject Grey Matter Graphs in Alzheimer's Disease
by: Betty M. Tijms, et al.
Published: (2013-01-01)

Correction: Single-Subject Grey Matter Graphs in Alzheimer's Disease.
by: Betty M. Tijms, et al.
Published: (2013-01-01)

Amyloid‐β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest‐old
by: Wiesje Pelkmans, et al.
Published: (2021-02-01)

Automatic MRI Quantifying Methods in Behavioral-Variant Frontotemporal Dementia Diagnosis
by: Antti Cajanus, et al.
Published: (2018-02-01)

Computer‐assisted prediction of clinical progression in the earliest stages of AD
by: Hanneke F.M. Rhodius‐Meester, et al.
Published: (2018-01-01)

Cerebral Blood Flow and Cognitive Functioning in a Community-Based, Multi-Ethnic Cohort: The SABRE Study
by: Anna E. Leeuwis, et al.
Published: (2018-09-01)

Gray Matter Network Disruptions and Regional Amyloid Beta in Cognitively Normal Adults
by: Mara ten Kate, et al.
Published: (2018-03-01)

Widespread disruption of functional brain organization in early-onset Alzheimer's disease.
by: Sofie M Adriaanse, et al.
Published: (2014-01-01)

PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases
by: Juhan Reimand, et al.
Published: (2019-12-01)

Multi-method analysis of MRI images in early diagnostics of Alzheimer's disease.
by: Robin Wolz, et al.
Published: (2011-01-01)

The Association Between Distinct Frontal Brain Volumes and Behavioral Symptoms in Mild Cognitive Impairment, Alzheimer's Disease, and Frontotemporal Dementia
by: Antti Cajanus, et al.
Published: (2019-10-01)

Methylphenidate and galantamine in patients with vascular cognitive impairment–the proof-of-principle study STREAM-VCI
by: Jolien F. Leijenaar, et al.
Published: (2020-01-01)

Improved classification of Alzheimer's disease data via removal of nuisance variability.
by: Juha Koikkalainen, et al.
Published: (2012-01-01)

Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
by: Tessa Timmers, et al.
Published: (2019-07-01)

Hypometabolism of the posterior cingulate cortex is not restricted to Alzheimer's disease
by: Nienke M.E. Scheltens, et al.
Published: (2018-01-01)

Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage
by: Simon-Shlomo ePoil, et al.
Published: (2013-10-01)

Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
by: Flora H. Duits, et al.
Published: (2018-01-01)

Slowing of hippocampal activity correlates with cognitive decline in early-onset Alzheimer’s disease. An MEG study with virtual electrodes.
by: Marjolein M.A. Engels, et al.
Published: (2016-05-01)

Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease
by: Rosha Babapour Mofrad, et al.
Published: (2019-12-01)

Exercise and Early-Onset Alzheimer’s Disease: Theoretical Considerations
by: Astrid M. Hooghiemstra, et al.
Published: (2012-04-01)

Effect of long‐term storage in biobanks on cerebrospinal fluid biomarker Aβ1‐42, T‐tau, and P‐tau values
by: Eline A.J. Willemse, et al.
Published: (2017-01-01)

Lumbar puncture in patients with neurologic conditions
by: Rosha Babapour Mofrad, et al.
Published: (2017-01-01)

The effect of amyloid pathology and glucose metabolism on cortical volume loss over time in Alzheimer's disease
by: Ossenkoppele, Rik, et al.
Published: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lpns71i41vb5cn7rmdclkbbebo